🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.

Several professionals said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has removed problematic material and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the platform secure and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

Within moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show dark colored parcels with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially significant medical dangers”.